We also found that 2P23-PRO140SC displayed synergistic effects with the previously designed bispecific inhibitors 2P23-iMab and m36.4-PRO140, which potently blocked HIV-1 infection through CD4-anchoring or CCR5 anchoring. This evidence concerns the gene CCR5 and HIV-1 infection.